Brd4 inhibition ameliorates Pyocyanin-mediated macrophage dysfunction via transcriptional repression of reactive

Feimei Zhu1, Feng Xiong2, Jinchen He1

  • 1Department of Pathophysiology, West China College of Basic medical sciences & Forensic Medicine, Sichuan University, 610041, Chengdu, China.

Cell Death & Disease
|June 17, 2020
PubMed

Insights

Pseudomonas aeruginosa

Area of Science:

  • Immunology
  • Microbiology
  • Cellular Biology

Background:

  • Macrophages are crucial for immune defense against Pseudomonas aeruginosa (PA) infections.
  • Phenazine-pyocyanin (PCN), a PA virulence factor, causes oxidative damage, but its effect on macrophages is unclear.
  • Understanding PCN's impact on macrophage function is vital for treating PA infections.

Purpose of the Study:

  • To investigate PCN's cytotoxicity in macrophages.
  • To elucidate the roles of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in PCN-induced macrophage damage.
  • To explore Bromodomain and extra-terminal (BET) proteins as potential therapeutic targets.

Main Methods:

  • Assessed PCN-induced ROS and RNS production in macrophages.
  • Utilized the small molecule inhibitor JQ1 to target BET proteins and iNOS.
  • Evaluated macrophage viability, bacterial clearance, and lung inflammation in a mouse model.

Main Results:

  • PCN impairs macrophage viability and function through ROS and novel RNS pathways.
  • JQ1 inhibited iNOS-dependent nitric oxide (NO) production by preventing Brd4 recruitment to the NOS2 promoter.
  • JQ1 treatment reduced peroxynitrite formation, improved macrophage survival and bacterial clearance, and decreased lung inflammation in vivo.

Conclusions:

  • PCN-induced macrophage dysfunction involves ROS, RNS, and Brd4-dependent transcriptional modulation.
  • Targeting Brd4 with inhibitors like JQ1 shows therapeutic potential against PA infections.
  • This study reveals a new mechanism of PCN toxicity and a promising therapeutic strategy.